Conflicts of interest: GE, Abbott, Edwards (honoraria)
|
|
|
- Margaret Merritt
- 5 years ago
- Views:
Transcription
1 Understanding Diastole and Its Contribution to Heart Failure: State of the Art in 2016 James D. Thomas, MD, FACC, FASE Director, Center for Heart Valve Disease Bluhm Cardiovascular Institute Professor of Medicine, Feinberg School of Medicine, Northwestern University Chicago, Illinois Conflicts of interest: GE, Abbott, Edwards (honoraria)
2 Poor Outcome in HFpEF is Long Known Survival for EF 50% and <50% Survival Expected EF = <50% EF = 50% p= Years EF = <50% EF = 50% Senni et al. Circulation 1998; 98:
3 Poor Outcome in HFpEF Survival for EF 50% and <50% Owan T et al. N Engl J Med 2006; 355:
4 Poor Outcome in HFpEF Survival for EF 50% and <50% As bad as advanced lung cancer! Owan T et al. N Engl J Med 2006; 355:
5 Increasing Frequency of HFpEF Prevalence for EF 50% and <50% Owan T et al. N Engl J Med 2006;355:
6 Increasing Prevalence of HFpEF GWTG-HF: 110,621 HF Hospitalizations Steinberg et al. Circulation 2012; 126: 65-75
7 What s New in HFpEF? New ways of grading diastolic dysfunction New ways to categorize patients Novel approaches to treatment
8 It Used to Seem So Simple Patterns of Diastolic Function In the beginning (mid 80s) There was good and evil
9 It Used to Seem So Simple Patterns of Diastolic Function In the beginning (mid 80s) But some sick patients still looked like this
10 It Used to Seem So Simple Patterns of Diastolic Function In the beginning (mid 80s) And the sickest of all looked like this
11 And We Struggled to Understand Pseudonormaliztion In the beginning (mid 80s) Thomas et al. JACC 1990; 16:
12 Integrating Multiple New Parameters PV Flow, TDI, Color M-mode, LA volume D S S AR E A
13 Use of Additional Parameters PV Flow, Tissue Doppler, Color M-mode E A Mitral inflow Mitral Inflow S D PV flow PV flow S m TDE Tissue Doppler A m E m CMM - Vp Color M-mode v p Nl (young) NL (Young) Nl (adult) NL (Adult) Delayed relaxation Delayed Relaxation Pseudo normal Pseudo normal Restrictive Restrictive Garcia, Thomas & Klein JACC 1998; 32:
14 31 yo Man MV: E:A = 2 PV: S>D Lateral e = 15 cm/sec E/e = 7.5 CMM: V p = 65 cm/sec
15 What s the Diastolic Function? 1) Normal 2) Stage 1 3) Stage 2 4) Stage 3 5) Stage 4
16 What s the Diastolic Function? 1) Normal 2) Stage 1 3) Stage 2 4) Stage 3 5) Stage 4
17 31 yo Man Septic and cardiogenic shock 2d after appendectomy PE: BP 96/72, HR 86, RA 20, PA 41/28, PCW 26, CI 1.5 Meds: Dopa, dobut, nipride, NTG, IABP
18 Guidelines Approach to Grading Diastolic Dysfunction Septal e Lateral e LA volume Big Problem There are 8 combinations of these parameters, but only 3 fit the algorithm! Septal e 8 Lateral e 10 LA < 34 ml/m2 Septal e 8 Lateral e 10 LA 34 ml/m2 Septal e < 8 Lateral e < 10 LA 34 ml/m2 E/A < 0.8 DT > 200 ms Av. E/e 8 Ar-A < 0 ms Val E/A < 0.5 E/A DT ms Av. E/e 9-12 Ar-A 30 ms Val E/A 0.5 E/A 2 DT < 160 ms Av. E/e 13 Ar-A 30 ms Val E/A 0.5 Normal. function Normal function, Athlete s heart, or constriction Grade I Grade II Grade III Nagueh et al. JASE 2009; 22:
19 A Room with Eight Ways Out But 5 of them are locked!
20 How Well Do These Work in Practice? 401 consecutive patients, age 59±16 years (60%M) Using only the 3 primary classifiers (LAVi, septal and lateral e ), diastolic function could be assigned in only 34% of cases For the 5 secondary indices (E/A ratio, E deceleration time, E/E, PV AR reversal duration, and E/A with Valsalva), concordance (3+/5 indices in agreement) occurred in only 64% of cases. Let s take another swing at the guidelines!
21 Nagueh et al. JASE 2016; 29:
22 Normal LV LVEF < 50% or other LV disease
23 Will the new guidelines be more applicable??? Time will tell, but clear there are many indeterminate cases
24 What s New in HFpEF? New ways of grading diastolic dysfunction New ways to categorize patients Novel approaches to treatment
25 The Many Faces of HFpEF Many thanks to Sanjiv Shah, MD, for some of these slides
26 The Many Faces of HFpEF
27 Clinical Categories of HFpEF Garden variety HFpEF (HTN, obesity, DM, CKD) CAD-HFpEF Right heart failure HFpEF AF predominante HfpEF HCM-like HFpEF High-output HFpEF Valvular HFpEF (multiple moderate lesions) Zebras: Constriction, amyloid (treatable) Oktay AA, Shah SJ. Curr Cardiol Rev 2014
28 397 HFpEF patients with detailed clinical, lab, ECG, and echo phenotyping (67 variables) Unbiased hierarchical clustering analysis 3 distinct groups identified 1: younger, lower BNP, less LVH and DD 2: most DM, obesity, OSA, lowest e, highest PCW and PVR 3: older, highest BNP, worst CKD, most electrical and echo changes, highest E/e, RV dysfunction Shah et al. Circulation 2015; 131;
29
30 Very Different Outcomes in the Three Groups Shah et al. Circulation 2015; 131;
31 What s New in HFpEF? New ways of grading diastolic dysfunction New ways to categorize patients Novel approaches to treatment
32 Key role of inflammation, altered signaling, fibrosis Circulation 2016; 134: 73-90
33 Matrix Approach to Therapy Matching Predisposing Factors and Clinical Presentation Bold: proven therapy; unbold: logical, promising, but unproven Shah et al. Circulation 2016; 134: 73-90
34 80+% of HFpEF patients Bold: proven therapy; unbold: logical, promising, but unproven Shah et al. Circulation 2016; 134: 73-90
35 Therapeutic Targets for HFpEF Diuresis Reduction in congestion/edema Improved RV afterload Lower PASP Better RV function Improved natriuresis/renal function Improved outcome with careful monitoring
36
37 80+% of HFpEF patients Almost universal Bold: proven therapy; unbold: logical, promising, but unproven Shah et al. Circulation 2016; 134: 73-90
38 Therapeutic Targets for HFpEF Weight Loss and Exercise Training Obesity and inactivity are risk factors for DM, HTN, HL Obesity also pro-inflammatory and impairs cardiac, renal, arterial, and skeletal muscle function Fat infiltration in muscle reduces O 2 diffusion and lowers A-V O 2 difference
39 23 HFpEF patients, 15 healthy controls (HC) Leg MRI to define skeletal muscle (SM) and intramuscular fat (IMF) Haykowsky et al. AJC 2014; 113:
40 100 obese patients with HFpEF 2x2 design randomized for diet (D), exercise (E), both, or neither (control) Outcomes: exercise capacity and QOL, with a host of secondary ones 20 week trial, 84% adherence to exercise, 99% to diet Weight loss Control: 1 Kg Exercise: 4 Kg Diet: 7 Kg Diet + exercise: 11 Kg Kitzman et al. JAMA 2016; 315: 36-46
41 Diet and Exercise Work! AT = aerobic training; CR = calorie restriction Kitzman et al. JAMA 2016; 315: 36-46
42 Matrix Approach to Therapy Novel Approaches Bold: proven therapy; unbold: logical, promising, but unproven Shah et al. Circulation 2016; 134: 73-90
43 Rationale for Testing Nitrites in HFpEF Nitrites are very different from nitrates Endothelial dysfunction plays a central role in HFpEF Nitrites improve endothelial function Nitrates my actually worsen endothelial function via increased ROS There is strong preliminary preliminary data for nitrites in HFpEF (both oral and inhaled forms) Some evidence that nitrate (as beetroot juice) can improve exercise tolerance
44 Acute Infusion of Sodium Nitrite Improvement in LV and RV Hemodynamics Borlaug et al. JACC 2015; 66:
45 Additional Targets for Therapy Novel Approaches Pleiotropic benefits of cgmp and protein kinase G cascade Importance of fibrosis and anti-fibrotic therapy Supporting trials of spironolactone (TOPCAT), and valsartan/sacubitril (PARAMOUNT)
46
47 1 Outcome (CV Death, HF Hosp, or Resuscitated Cardiac Arrest) 351/1723 (20.4%) Placebo Spironolactone HR = 0.89 ( ) p= /1722 (18.6%) Pitt et al. NEJM 2014
48 Placebo Rates: Primary Outcome, by region US, Canada, Argentina, Brazil 12.6 per 100 pt-yr Placebo: 280/881 (31.8%) Russia, Rep Georgia 2.3 per 100 pt-yr Placebo: 71/842 (8.4%) Pfeffer et al. Circulation 2015
49 Exploratory (post-hoc): Placebo vs. Spiro by region US, Canada, Argentina, Brazil HR=0.82 ( ) Placebo: 280/881 (31.8%) Interaction p=0.122 Placebo: 71/842 (8.4%) Russia, Rep Georgia HR=1.10 ( ) Pfeffer et al. Circulation 2015
50 Lancet 2016; 387: 1290 Lancet 2016; 387: 1297
51 Lancet 2016; 387: 1290 Lancet 2016; 387: 1297
52 An Exciting Program to Come Thanks for your attention!
53 Hoping to Welcome You in Chicago Thanks for your attention!
Diastolic Function Assessment Practical Ways to Incorporate into Every Echo
Diastolic Function Assessment Practical Ways to Incorporate into Every Echo Jae K. Oh, MD Echo Hawaii 2018 2018 MFMER 3712003-1 Learning Objectives My presentation will help you to Appreciate the importance
Diastolic Heart Function: Applying the New Guidelines Case Studies
Diastolic Heart Function: Applying the New Guidelines Case Studies Mitral Regurgitation The New ASE William Guidelines: A. Zoghbi Role MD, of FASE, 2D/3D MACCand CMR Professor and Chairman, Department
THE PROPER APPROACH TO DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION
THE PROPER APPROACH TO DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION James C. Fang, MD, FACC Professor and Chief Cardiovascular Division University of Utah School of Medicine Disclosures Data
Diastole is Not a Single Entity Four Components of Diastolic Dysfunction
Physiology of Diastolic Function Made Easy James D. Thomas, MD, FACC, FASE Director, Center for Heart Valve Disease Bluhm Cardiovascular Institute Professor of Medicine, Feinberg School of Medicine, Northwestern
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling
Therapeutic Targets and Interventions
Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium
Diastolic Function Assessment New Guideline Update Practical Approach
Mayo Clinic Department of Cardiovascular Diseases Mayo Clinic Echocardiography Review Course for Boards and Recertification Diastolic Function Assessment New Guideline Update Practical Approach Jae K.
HFpEF, Mito or Realidad?
HFpEF, Mito or Realidad? Ileana L. Piña, MD, MPH Professor of Medicine and Epidemiology/Population Health Associate Chief for Academic Affairs -- Cardiology Montefiore-Einstein Medical Center Bronx, NY
Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD
Imaging in Heart Failure: A Multimodality Approach Thomas Ryan, MD Heart Failure HFrEF HFpEF EF50% Lifetime risk 20% Prevalence 6M Americans Societal costs - $30B 50% 5-year survival 1 Systolic
Diastology State of The Art Assessment
Diastology State of The Art Assessment Dr. Mohammad AlGhamdi Assistant professor, KSAU-HS Consultant Cardiologist King AbdulAziz Cardiac Center Ministry of National Guard Health Affairs Diagnostic Clinical
Choose the grading of diastolic function in 82 yo woman
Question #1 Choose the grading of diastolic function in 82 yo woman E= 80 cm/s A= 70 cm/s LAVI < 34 ml/m 2 1= Grade 1 2= Grade 2 3= Grade 3 4= Normal 5= Indeterminate 2018 MFMER 3712003-1 Choose the grading
Diastolic Function Overview
Diastolic Function Overview Richard Palma BS, RDCS, RCS, APS, FASE Director and Clinical Coordinator The Hoffman Heart and Vascular Institute School of Cardiac Ultrasound None Disclosures Learning Objectives
DECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST ESC Congress 2011 Pathophysiology of HFPEF Vascular Remodeling & Pulmonary Hypertension Carolyn S.P. Lam MBBS, MRCP, MS Case Presentation 81 yo woman with dyspnoea &
OPTIMIZING ECHO ACQUISTION FOR STRAIN AND DIASTOLOGY
OPTIMIZING ECHO ACQUISTION FOR STRAIN AND DIASTOLOGY October 8, 2017 Deborah Agler, ACS, RDCS, FASE Coordinator of Education and Training Cleveland Clinic General Principles Diastology Clinical Data Heart
Heart Failure with Preserved Ejection Fraction. April 4, 2018 Mike Muellerleile M.D.
Heart Failure with Preserved Ejection Fraction April 4, 2018 Mike Muellerleile M.D. Heart Failure with Preserved Ejection Fraction Introduction Clinical Description of HFpEF Pathophysiology of HFpEF
Dr.Fayez EL Shaer Consultant cardiologist Assistant professor of cardiology KKUH
Pulmonary Hypertension in patients with Heart Failure with Preserved Ejection Fraction Dr.Fayez EL Shaer Consultant cardiologist Assistant professor of cardiology KKUH Recent evaluation of available data
An Integrated Approach to Study LV Diastolic Function
An Integrated Approach to Study LV Diastolic Function Assoc. Prof. Adriana Ilieşiu, FESC University of Medicine Carol Davila Bucharest, Romania LV Diastolic Dysfunction impaired relaxation (early diastole)
HF-Preserved Ejection Fraction
HF-Preserved Ejection Fraction Justin A. Ezekowitz, MBBCh MSc FRCPC FACC FESC FAHA Associate Professor, University of Alberta Co-Director, Canadian VIGOUR Centre Cardiologist, Mazankowski Alberta Heart
Heart Failure Guidelines For your Daily Practice
Heart Failure Guidelines For your Daily Practice Juan M. Aranda, Jr., MD, FACC, FHFSA Professor of Medicine Director of Heart Failure and Cardiac Transplantation University of Florida College of Medicine
HFpEF. April 26, 2018
HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes
The Patient with Atrial Fibrilation
Assessment of Diastolic Function The Patient with Atrial Fibrilation Assoc. Prof. Adriana Ilieşiu, FESC University of Medicine Carol Davila Bucharest, Romania Associated Conditions with Atrial Fibrillation
GENERAL PRINCIPLES FOR ECHO ASSESSMENT OF DIASTOLIC FUNCTION (For full recommendation refer to the Left Ventricular Diastolic Function Guideline)
1 THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY RECOMMENDATIONS FOR THE EVALUATION OF LEFT VENTRICULAR DIASTOLIC FUNCTION BY ECHOCARDIOGRAPHY: A QUICK REFERENCE GUIDE FROM THE ASE WORKFLOW AND LAB MANAGEMENT
Treatment Of Preserved Cardiac Function Heart Failure with an Aldosterone antagonist (TOPCAT) AHA Nov 18, 2014 Update on Randomized Trials
Treatment Of Preserved Cardiac Function Heart Failure with an Aldosterone antagonist (TOPCAT) AHA Nov 18, 2014 Update on Randomized Trials Marc A. Pfeffer, MD, PhD; Brian Claggett, PhD; Susan F. Assmann,
HFpEF: How to optimise management
HFpEF: How to optimise management Burkert Pieske M.D. Berlin, Germany Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, and Department of Internal
HFNEF. Heart Failure is
HFNEF Bijoy K. Khandheria, MD. FASE, FACP, FACC FESC Professor of Medicine University of Wisconsin Director. Echocardiography Services Aurora Health Care No conflicts or off label use CP1173868-1 Heart
Diastolic Heart Failure Uri Elkayam, MD
Diastolic Heart Failure Uri Elkayam, MD Professor of Medicine University of Southern California School of Medicine Los Angeles, California elkayam@usc.edu Diastolic Heart Failure Clinical Definition A
Objectives. Let s start at the beginning 10/28/2014. What is Heart Failure? Understanding Heart Failure with Preserved LV Systolic Function
Understanding Heart Failure with Preserved LV Systolic Function Eric Ernst, MD Medical Director C.O.R.E. Clinic Objectives Clarify the terminology surrounding right heart failure and diastolic heart failure
HFpEF: Pathophysiology & Treatment
HFpEF: Pathophysiology & Treatment Barry A. Borlaug, MD Mayo Clinic, Rochester, MN borlaug.barry@mayo.edu Disclosure Financial Relationships Research Support: Aires Pharmaceuticals, Medtronic, GSK Consulting/Advisory
CASES IN ADVANCED IMAGING
CASES IN ADVANCED IMAGING DAVID A. ORSINELLI, MD PROFESSOR, CLINICAL INTERNAL MEDICINE THE OHIO STATE UNIVERSITY DIVISION OF CARDIOVASCULAR MEDICINE OHIO ACC ANNUAL CONFERENCE OCTOBER 2010 WHICH IMAGING
HFPEF Echo with Strain vs. MRI T1 Mapping
HFPEF Echo with Strain vs. MRI T1 Mapping Erik Schelbert, MD MS Director, Cardiovascular Magnetic Resonance Assistant Professor of Medicine Heart & Vascular Institute University of Pittsburgh Disclosures
The Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University
The Athlete s Heart Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. Disclosures Grant support (to institution) for Core
Constriction vs Restriction Case-based Discussion
Mayo Clinic Department of Cardiovascular Diseases Mayo Clinic Echocardiography Review Course for Boards and Recertification Constriction vs Restriction Case-based Discussion Jae K. Oh, MD Samsung Professor
Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre
Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:
Echo in Systemic Disease
Echo in Systemic Disease Vera H. Rigolin, MD, FASE, FACC, FAHA Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Echocardiography Laboratory Northwestern Memorial
Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on)
Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on) N.Koutsogiannis) Department)of)Cardiology) University)Hospital)of)Patras)! I have no conflicts of interest
HFpEF 2016 : Comorbidities and Outcomes
HFpEF 2016 : Comorbidities and Outcomes Christopher M. O Connor, MD, FACC CEO and Executive Director, Inova Heart and Vascular Institute Professor of Medicine, Duke University Editor in Chief, JACC: Heart
Objectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009
Objectives Diastolic Heart Failure and Indications for Echocardiography in the Asian Population Damon M. Kwan, MD UCSF Asian Heart & Vascular Symposium 02.07.09 Define diastolic heart failure and differentiate
Managing the Low Output Low Gradient Aortic Stenosis Patient
Managing the Low Output Low Gradient Aortic Stenosis Patient R A Nishimura MD Judd and Mary Leighton Professor of CV Mayo Clinic No disclosures Valvular Stenosis Severity of Aortic Stenosis Mean gradient
Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef
Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives
Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies
Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies Mitral Regurgitation The New ASE Guidelines: Role of 2D/3D and CMR William A. Zoghbi MD, FASE, MACC Professor and
E/Ea is NOT an essential estimator of LV filling pressures
Euroecho Kopenhagen Echo in Resynchronization in 2010 E/Ea is NOT an essential estimator of LV filling pressures Wilfried Mullens, MD, PhD December 10, 2010 Ziekenhuis Oost Limburg Genk University Hasselt
Pulmonary Hypertension: Another Use for Viagra
Pulmonary Hypertension: Another Use for Viagra Kathleen Tong, MD Director, Heart Failure Program Assistant Clinical Professor University of California, Davis Disclosures I have no financial conflicts A
Ejection Fraction in Patients With Chronic Heart Failure. Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction
Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction Keith Miller MD Diastolic Heart Failure Risk Factors Common Risk Factors Aging Female gender Obesity Hypertension Diabetes mellitus
DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES
THORAXCENTRE DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES J. Roelandt DOPPLER HEMODYNAMICS Intracardiac pressures and pressure gradients Volumetric measurement
Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.
Echo Doppler Assessment of Right and Left Ventricular Hemodynamics. Itzhak Kronzon, MD, FASE, FACC, FESC, FAHA, FACP, FCCP Northwell, Lenox Hill Hospital, New York Professor of Cardiology Hofstra University
What to do with a Patient with Recurrent MR after Intervention
What to do with a Patient with Recurrent MR after Intervention James D. Thomas, MD, FACC, FASE Director, Center for Heart Valve Disease Bluhm Cardiovascular Institute Professor of Medicine, Feinberg School
Diastolic Function: What the Sonographer Needs to Know. Echocardiographic Assessment of Diastolic Function: Basic Concepts 2/8/2012
Diastolic Function: What the Sonographer Needs to Know Pat Bailey, RDCS, FASE Technical Director Beaumont Health System Echocardiographic Assessment of Diastolic Function: Basic Concepts Practical Hints
AHA Nov 18, 2013 Late Breaking Session
Treatment Of Preserved Cardiac Function Heart Failure with an Aldosterone antagonist (TOPCAT) AHA Nov 18, 2013 Late Breaking Session Marc A. Pfeffer MD, PhD, on behalf of the TOPCAT Investigators TOPCAT
Diastology Disclosures: None. Dias2011:1
Diastology 2011 James D. Thomas, M.D., F.A.C.C. Cardiovascular Imaging Center Department of Cardiology Cleveland Clinic Foundation Cleveland, Ohio, USA Disclosures: None Dias2011:1 Is EVERYBODY a member!?!
Heart Failure with Preserved Ejection Fraction: Myths and Misconceptions
N E W F R O N T I E R S I N H E A R T F A I L U R E T H E R A P Y 2 0 1 5 Heart Failure with Preserved Ejection Fraction: Myths and Misconceptions J A N U A R Y 2 4, 2 0 1 5 Sanjiv J. Shah, MD, FAHA, FACC
LA Function analysis Marcia Barbosa Vice Presidente - Brazilian Soc of Cardiology President-elect - Interamerican Soc of Cardiology
LA Function analysis Marcia Barbosa Vice Presidente - Brazilian Soc of Cardiology President-elect - Interamerican Soc of Cardiology Belo Horizonte Brazil DECLARATION OF CONFLICT OF INTEREST Nothing to
Pulmonary Hypertension Due to Left Heart Disease
ACC Middle East Conference 2018 Pulmonary Hypertension Due to Left Heart Disease Ammar Chaudhary, MBChB, FRCPC Advanced Heart Failure & Transplantation King Faisal Specialist Hospital and Research Center
Pericardial Disease: Case Examples. Echo Fiesta 2017
Pericardial Disease: Case Examples Echo Fiesta 2017 2014 2014 MFMER MFMER 3346252-1 slide-1 Objectives Have a systematic approach to evaluation of constriction 2014 MFMER 3346252-2 CASE 1 2013 MFMER 3248567-3
Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter.
Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter. Itzhak Kronzon, MD, FASE, FACC, FESC, FAHA, FACP, FCCP North Shore HS, LIJ/Lenox Hill Hospital, New York
Diastolic Heart Failure (HFpEF) Felix J. Rogers, DO, FACOI April 29, 2018
Diastolic Heart Failure (HFpEF) Felix J. Rogers, DO, FACOI April 29, 2018 Case presentation MSO, an 81 year old woman was admitted to HFWH because of progressive dyspnea and difficult to control hypertension
Left ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy
Left ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania My conflicts of interest: I have
LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital
LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV inflow across MV LV LV outflow across AV LV LV geometric changes Pressure overload
MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS
MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine Director, Structural Heart Imaging The Ohio State University
How to Assess Diastolic Dysfunction?
How to Assess Diastolic Dysfunction? Fausto J Pinto, MD, PhD, FESC, FACC, FASE Lisbon University Dyastolic Dysfunction Impaired relaxation Elevated filling pressures Ischemic heart disease Cardiomyopathies
Heart Failure with preserved ejection fraction (HFpEF)
Heart Failure with preserved ejection fraction (HFpEF) Dr. Pierpaolo Pellicori Hull York Medical School Kingston-upon-Hull United Kingdom Conflict of interest: none Heart failure is a contemporary problem
Hypertensive heart disease and failure
Hypertensive heart disease and failure Prof. Dr. Alan Fraser Cardiff University The heart in hypertension Pathophysiology of LV adaptation Regional development of hypertrophy Stress testing - inducible
Therapeutic Targets and Interventions. Ali Valika, MD, FACC Advocate Medical Group
Therapeutic Targets and Interventions Ali Valika, MD, FACC Advocate Medical Group Disclosures: 1. Novartis: Speaker Honorarium Diastolic Heart Failure Diastolic heart failure (DHF) is a major cause of
Heart Failure with Preserved EF (HFPEF) Epidemiology and management
Heart Failure with Preserved EF (HFPEF) Epidemiology and management Karl Swedberg Senior Professor of Medicine Sahlgrenska Academy University of Gothenburg Gothenburg, Sweden e-mail: karl.swedberg@gu.se
Ejection Fraction in Heart Failure: A Redefinition. Tarek Kashour King Fahad Cardiac Center King Saud University Riyadh, KSA
Ejection Fraction in Heart Failure: A Redefinition Tarek Kashour King Fahad Cardiac Center King Saud University Riyadh, KSA Word of caution!!! Incomplete understanding of a disease process may lead to
ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ ΜΕ ΔΙΑΤΗΡΗΜΕΝΟ ΚΛΑΣΜΑ ΕΞΩΘΗΣΗΣ
ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ ΜΕ ΔΙΑΤΗΡΗΜΕΝΟ ΚΛΑΣΜΑ ΕΞΩΘΗΣΗΣ ΙΓΝΑΤΙΟΣ ΟΙΚΟΝΟΜΙΔΗΣ MD, PHD, FESC ΑΝΑΠΛΗΡΩΤΗΣ ΚΑΘΗΓΗΤΗΣ ΚΑΡΔΙΟΛΟΓΙΑΣ Β ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ, ΕΘΝΙΚΌ ΚΑΙ ΚΑΠΟΔΙΣΤΡΙΑΚΌ ΠΑΝΕΠΙΣΤΗΜΙΟ ΑΘΗΝΩΝ ΝΟΣΟΚΟΜΕΙΟ
Management of Heart Failure from diagnosis to the grave. Richard Lawrance Consultant Cardiologist - WMH
Management of Heart Failure from diagnosis to the grave Richard Lawrance Consultant Cardiologist - WMH Case Presentation 55y man Breathless Ex tolerance 100yds on flat, limited by SOB No chest pain Borderline
Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi
Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi Identify increased LV wall thickness (WT) Understand increased WT in athletes Understand hypertrophic cardiomyopathy (HCM) Enhance understanding
Strategie di Prevenzione del Rischio CCV Globale. La diagnosi pre-clinica della disfunzione ventricolare sinistra
Strategie di Prevenzione del Rischio CCV Globale 1^ edizione: 13 novembre 2010 ore 9.00-13.00 SALA CARAVAGGIO - FIERA DI BERGAMO Via Lunga BERGAMO Per i MAP dei distretti di: Seriate Grumello Valle Cavallina
Sleep Disordered Breathing and HH with Preserved Ejection Fraction:
Sleep Disordered Breathing and HH with Preserved Ejection Fraction: Pr Thibaud DAMY Heart Failure Unit Department of Cardiology CHU Mondor, Créteil, France Definition of HF-PEF The diagnosis of HF-PEF
Heart Failure with Preserved Left Ventricular Ejection Fraction. (HFpEF)
Thessaloniki, May 27, 2017 Heart Failure with Preserved Left Ventricular Ejection Fraction Filippos Triposkiadis, MD, FESC, FACC Professor of Cardiology Director, Department of Cardiology Larissa University
THE DIASTOLIC STRESS TEST: A NEW CLINICAL TOOL? THE CONCEPT OF DIASTOLIC RESERVE
Thierry C. Gillebert University of Ghent ESC Education Committee THE DIASTOLIC STRESS TEST: A NEW CLINICAL TOOL? THE CONCEPT OF DIASTOLIC RESERVE 1 Case: Ann, 63 years Suffered from metabolic syndrome
Diastolic Heart Failure
Chronic Heart Failure Prevalence overall = 2-3 % Diastolic Heart Failure Patrick Wouters University Hospital Ghent Belgium (Heart Failure + Asymptomatic Ventricular Dysfunction) Prevalence > 70 y = 10-20
Usually we DON T need to go beyond the gradient
Aortic Stenosis Going Beyond the Gradient James D. Thomas, MD, FACC, FASE Director, Center for Heart Valve Disease Bluhm Cardiovascular Institute Professor of Medicine, Feinberg School of Medicine, Northwestern
Taking the FAILURE out of CHF Denzil Moraes, MD, FACC
Taking the FAILURE out of CHF Denzil Moraes, MD, FACC Our Lady of the Lake Heart & Vascular Institute CHAIR Heart Failure Committee The Burden of Heart Failure Prevalence of Heart Failure ~ Currently 5.7
The new Guidelines: Focus on Chronic Heart Failure
The new Guidelines: Focus on Chronic Heart Failure Petros Nihoyannopoulos MD, FRCP, FESC Professor of Cardiology Imperial College London and National & Kapodistrian University of Athens 2 3 4 The principal
Heart Failure with Preserved Ejection Fraction (HFpEF): Natural History and Contemporary Management
Heart Failure with Preserved Ejection Fraction (HFpEF): Natural History and Contemporary Management Jason L. Guichard, MD, PhD Greenville Health System Department of Medicine, Carolina Cardiology Consultants
M-Mode Echocardiography Is it still Alive? Itzhak Kronzon, MD,FASE. Sampling Rate M-Mode: 1800 / sec 2D: 30 / sec
M-Mode Echocardiography Is it still Alive? Itzhak Kronzon, MD,FASE Honoraria: Philips Classical M-mode Echocardiography M-Mode offers better time and image resolution. Sampling Rate M-Mode: 1800 / sec
Transcatheter InterAtrial Shunt Device for the Treatment of Heart Failure: Results From the REDUCE LAP-HF I Randomized Controlled Trial
A M E R I C A N H E A R T A S S O C I A T I O N S C I E N T I F I C S E S S I O N S 2 0 1 7 Transcatheter InterAtrial Shunt Device for the Treatment of Heart Failure: Results From the REDUCE LAP-HF I Randomized
Optimal blockade of the Renin- Angiotensin-Aldosterone. in chronic heart failure
Optimal blockade of the Renin- Angiotensin-Aldosterone Aldosterone- (RAA)-System in chronic heart failure Jan Östergren Department of Medicine Karolinska University Hospital Stockholm, Sweden Key Issues
Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None
Athlete's Heart vs. Cardiac Pathology Clinical Approaches Echo Florida 2012 Aaron L. Baggish MD Cardiovascular Performance Program Cardiac Ultrasound Laboratory Division of Cardiology Massachusetts General
P = 4V 2. IVC Dimensions 10/20/2014. Comprehensive Hemodynamic Evaluation by Doppler Echocardiography. The Simplified Bernoulli Equation
Comprehensive Hemodynamic Evaluation by Doppler Echocardiography Itzhak Kronzon, MD North Shore LIJ/ Lenox Hill Hospital New York, NY Disclosure: Philips Healthcare St. Jude Medical The Simplified Bernoulli
The Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University
The Athlete s Heart Critical Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. Disclosures Grant support (to institution)
Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이
Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이 Outline Evaluation of Chest pain Evaluation of MI complications Prediction of Outcomes Evaluation of Chest pain Evaluation
Diastolic Function. Rick Nishimura Leighton Professor of CV Diseases Mayo Clinic No Disclosures
Diastolic Function Rick Nishimura Leighton Professor of CV Diseases Mayo Clinic No Disclosures Heart = Pump Heart Failure Systolic Dysfunction Diastolic Dysfunction Diastole is a complex sequence of multiple
Strain/Untwisting/Diastolic Suction
What Is Diastole and How to Assess It? Strain/Untwisting/Diastolic Suction James D. Thomas, M.D., F.A.C.C. Cardiovascular Imaging Center Department of Cardiology Cleveland Clinic Foundation Cleveland,
Atrial dysfunction and chronotropic incompetence
Pathophysiology of heart failure with preserved ejection fraction Atrial dysfunction and chronotropic incompetence Vojtech Melenovsky IKEM, Prague, Czech Republic DECLARATION OF CONFLICT OF INTEREST :
Echo-Doppler evaluation of left ventricular diastolic function. Michel Slama Amiens France
Echo-Doppler evaluation of left ventricular diastolic function Michel Slama Amiens France Left ventricular pressure Pressure A wave [ LVEDP LVEDP préa Congestive cardiac failure with preserved systolic
Association between RV Function in PPCM and LV Recovery & Clinical Outcome
Association between RV Function in PPCM and LV Recovery & Clinical Outcome Lori A Blauwet, MD, MA Associate Professor of Medicine Co-Director, Cardio-OB Clinic Mayo Clinic Rochester, MN USA 2016 MFMER
Vinod H. Thourani, MD
Triggers for Aortic Stenosis and Regurgitation Vinod H. Thourani, MD Professor of Surgery Chair, Department of Cardiac Surgery MedStar Heart and Vascular Institute Georgetown University Washington, DC,
Natural History and Echo Evaluation of Aortic Stenosis
Natural History and Echo Evaluation of Aortic Stenosis Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM AORTIC STENOSIS First valvular disease
Dr. Dermot Phelan MB BCh BAO PhD European Society of Cardiology 2012
Relative Apical Sparing of Longitudinal Strain Using 2- Dimensional Speckle-Tracking Echocardiography is Both Sensitive and Specific for the Diagnosis of Cardiac Amyloidosis. Dr. Dermot Phelan MB BCh BAO
Diabetes and the Heart
Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital
Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan
Role of Stress Echo in Valvular Heart Disease Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan Exercise echocardiography Dobutamine echocardiography Usefulness of exercise echo
Peripheral Contributions to HFpEF
Peripheral Contributions to HFpEF Greg Lewis MD Heart Failure Section Head MGH Cardiology Division and Pulmonary Critical Care Unit Harvard Medical School March 12, 2018 Pathophysiology of HFpEF vs. HFrEF
What to do for the Patient with Heart Failure and Preserved Ejection Fraction: HFpEF
What to do for the Patient with Heart Failure and Preserved Ejection Fraction: HFpEF Mariell Jessup MD, FAHA, FACC, FESC Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania Disclosure:
Diastolic Heart Failure
Diastolic Heart Failure Presented by: Robert Roberts, M.D., FRCPC, MACC, FAHA, FRSC Professor of Medicine and Chair ISCTR University of Arizona, College of Medicine Phoenix Scientist Emeritus and Advisor,
Michigan Society of Echocardiography 30 th Year Jubilee
Michigan Society of Echocardiography 30 th Year Jubilee Stress Echocardiography in Valvular Heart Disease Moving Beyond CAD Karthik Ananthasubramaniam, MD FRCP (Glas) FACC FASE FASNC Associate Professor
Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD
Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD Board Review Course 2017 43 year old health assistant Severe resistant HTN LT BSA 2 Height 64 1 Here is the M mode echocardiogram
New Approaches to Systolic Function: Strain Imaging
New Approaches to Systolic Function: Strain Imaging James D. Thomas, MD, FACC, FASE Director, Center for Heart Valve Disease Bluhm Cardiovascular Institute Professor of Medicine, Feinberg School of Medicine,
LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION
LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION Jamilah S AlRahimi Assistant Professor, KSU-HS Consultant Noninvasive Cardiology KFCC, MNGHA-WR Introduction LV function assessment in Heart Failure: